188 related articles for article (PubMed ID: 32481604)
1. Bayesian Regression Model for a Cost-Utility and Cost-Effectiveness Analysis Comparing Punch Grafting Versus Usual Care for the Treatment of Chronic Wounds.
Selva-Sevilla C; Conde-Montero E; Gerónimo-Pardo M
Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32481604
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility of a biofilm-disrupting gel versus standard of care in chronic wounds: a Markov microsimulation model based on a randomised controlled trial.
Carter MJ; Myntti MF
J Wound Care; 2019 Jul; 28(Sup7):S24-S38. PubMed ID: 31295074
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of negative pressure wound therapy in patients with many comorbidities and severe wounds of various etiology.
Driver VR; Eckert KA; Carter MJ; French MA
Wound Repair Regen; 2016 Nov; 24(6):1041-1058. PubMed ID: 27669667
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers.
Selva-Sevilla C; Fernández-Ginés FD; Cortiñas-Sáenz M; Gerónimo-Pardo M
PLoS One; 2021; 16(9):e0257494. PubMed ID: 34543330
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosis.
Soini E; Joutseno J; Sumelahti ML
Clin Ther; 2017 Mar; 39(3):537-557.e10. PubMed ID: 28209373
[TBL] [Abstract][Full Text] [Related]
7. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the ventricular assist device programme in the UK.
Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
[TBL] [Abstract][Full Text] [Related]
9. Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.
Nguyen CM; Bounthavong M; Mendes MA; Christopher ML; Tran JN; Kazerooni R; Morreale AP
Pharmacoeconomics; 2012 Jul; 30(7):575-93. PubMed ID: 22640174
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
[TBL] [Abstract][Full Text] [Related]
12. Punch grafting for pain reduction in hard-to-heal ulcers.
Conde-Montero E; de Farias Khayat Y; Pérez Jerónimo L; Vázquez AP; Marín LR; Guisado S; de la Cueva Dobao P
J Wound Care; 2020 Mar; 29(3):194-197. PubMed ID: 32160087
[TBL] [Abstract][Full Text] [Related]
13. Negative pressure wound therapy for surgical wounds healing by primary closure.
Webster J; Liu Z; Norman G; Dumville JC; Chiverton L; Scuffham P; Stankiewicz M; Chaboyer WP
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009261. PubMed ID: 30912582
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of the Geriatric Fracture Center (GFC) concept: a prospective multicentre cohort study.
Joeris A; Sprague S; Blauth M; Gosch M; Wattanapanom P; Jarayabhand R; Poeze M; Wong MK; Kwek EBK; Hegeman JH; Perez-Uribarri C; Guerado E; Revak TJ; Zohner S; Joseph D; Phillips MR
BMJ Open; 2023 Nov; 13(11):e072744. PubMed ID: 37918921
[TBL] [Abstract][Full Text] [Related]
15. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
[TBL] [Abstract][Full Text] [Related]
17. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
De Salas-Cansado M; Álvarez E; Olivares JM; Carrasco JL; Ferro MB; Rejas J
Soc Psychiatry Psychiatr Epidemiol; 2013 Jun; 48(6):985-96. PubMed ID: 23086587
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
Bhadhuri A; Dröschel D; Guldimann M; Jetschgo C; Banhazi J; Schwenkglenks M; Sutherland CS
BMC Health Serv Res; 2022 Jun; 22(1):837. PubMed ID: 35765055
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.
Salisbury C; Foster NE; Hopper C; Bishop A; Hollinghurst S; Coast J; Kaur S; Pearson J; Franchini A; Hall J; Grove S; Calnan M; Busby J; Montgomery AA
Health Technol Assess; 2013 Jan; 17(2):1-157, v-vi. PubMed ID: 23356839
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
